P Jandı́k

3.7k total citations · 1 hit paper
19 papers, 2.8k citations indexed

About

P Jandı́k is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, P Jandı́k has authored 19 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in P Jandı́k's work include Colorectal Cancer Treatments and Studies (5 papers), Trace Elements in Health (4 papers) and Genetic factors in colorectal cancer (3 papers). P Jandı́k is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Trace Elements in Health (4 papers) and Genetic factors in colorectal cancer (3 papers). P Jandı́k collaborates with scholars based in Czechia, Switzerland and Germany. P Jandı́k's co-authors include Matilde Navarro, G. Gruia, Timothy Iveson, Petr Karásek, J Carmichael, Lucile Awad, May Alakl, AD Roth, David Cunningham and P Rougier and has published in prestigious journals such as The Lancet, European Journal of Cancer and Clinica Chimica Acta.

In The Last Decade

P Jandı́k

18 papers receiving 2.7k citations

Hit Papers

Irinotecan combined with fluorouracil compared with fluor... 2000 2026 2008 2017 2000 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
    2000 2.5k citations J-Y Douillard, David Cunningham et al. The Lancet profile →

Peers

P Jandı́k
Paula K. Locker United States
May Alakl France
Nicoletta Pirotta United States
G. Gruia France
C. Wilson Canada
D. Papamichael United Kingdom
M. Homerin France
J-Y Douillard France
Axel Grothey United States
Daniel Hendler Israel
Paula K. Locker United States
P Jandı́k
Citations per year, relative to P Jandı́k P Jandı́k (= 1×) peers Paula K. Locker

Countries citing papers authored by P Jandı́k

Since Specialization
Citations

This map shows the geographic impact of P Jandı́k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Jandı́k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Jandı́k more than expected).

Fields of papers citing papers by P Jandı́k

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Jandı́k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Jandı́k. The network helps show where P Jandı́k may publish in the future.

Co-authorship network of co-authors of P Jandı́k

This figure shows the co-authorship network connecting the top 25 collaborators of P Jandı́k. A scholar is included among the top collaborators of P Jandı́k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Jandı́k. P Jandı́k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jandı́k, P, Leoš Fuksa, Aleš Ryška, et al.. (2012). Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen. Folia Biologica. 58(5). 185–192. 7 indexed citations
2.
Jandı́k, P, et al.. (2012). Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen (breastcancer/neoadjuvanttherapy/predictivebiomarkers).
3.
Beránek, Martin, et al.. (2007). Detection of Point Mutations in Kirsten ras 2 Gene Using Locked Nucleic Acids Clamped PCR. Chemické listy. 101(9). 1 indexed citations
4.
Melichar, Bohuslav, et al.. (2007). Fulminant course of metastatic liposarcoma after delivery--case report.. PubMed. 28(1). 67–8. 4 indexed citations
5.
6.
Melichar, Bohuslav, et al.. (2002). Intraarterial chemotherapy of malignant melanoma metastatic to the liver.. PubMed. 48(42). 1711–5. 10 indexed citations
7.
Dvořák, Josef, et al.. (2001). Pegylated Liposomal Doxorubicin in Combination with Hyperthermia for Treatment of Skin Metastases of Breast Carcinoma: A Case Report. Oncology Research and Treatment. 24(2). 166–168. 7 indexed citations
8.
Hronek, Miloslav, Z Zadák, Dagmar Solichová, P Jandı́k, & Bohuslav Melichar. (2000). The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition. 16(3). 189–191. 19 indexed citations
9.
Douillard, J-Y, David Cunningham, AD Roth, et al.. (2000). Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. The Lancet. 355(9209). 1041–1047. 2530 indexed citations breakdown →
10.
Stulík, Jiří, Jan Österreicher, Kamila Koupilová, et al.. (2000). Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. European Journal of Cancer. 36(8). 1050–1059. 47 indexed citations
11.
Beránek, Martin, et al.. (1999). A Relationship between K-ras Gene Mutations and Some Clinical and Histologic Variables in Patients with Primary Colorectal Carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM). 37(7). 723–727. 13 indexed citations
12.
Stulík, Jiří, Kamila Koupilová, Jan Österreicher, et al.. (1999). Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis. 20(18). 3638–3646. 68 indexed citations
13.
14.
Stulík, Jiří, Hana Kovářová, Aleš Macela, et al.. (1997). Overexpression of calcium-binding protein calgranulin B in colonic mucosal diseases. Clinica Chimica Acta. 265(1). 41–55. 19 indexed citations
15.
Melichar, Bohuslav, P Jandı́k, František Malíř, et al.. (1995). Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scandinavian Journal of Clinical and Laboratory Investigation. 55(2). 149–152. 8 indexed citations
16.
Melichar, Bohuslav, et al.. (1994). Urinary zinc excretion and acute phase response in cancer patients. Journal of Molecular Medicine. 72(12). 1012–1014. 11 indexed citations
17.
Melichar, Bohuslav, P Jandı́k, František Malíř, et al.. (1994). Increased urinary zinc and copper excretion in colorectal cancer.. PubMed. 8(3-4). 209–12. 4 indexed citations
18.
Stulík, Jiří, et al.. (1994). Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer.. PubMed. 4(3). 103–6. 5 indexed citations
19.
Tichý, M., Jan Bureš, & P Jandı́k. (1990). Importance of determining lysozyme in colorectal cancer.. PubMed. 33(3). 345–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula K. Locker Breakdown of academic impact, for papers by May Alakl Breakdown of academic impact, for papers by Nicoletta Pirotta Breakdown of academic impact, for papers by G. Gruia Breakdown of academic impact, for papers by C. Wilson Breakdown of academic impact, for papers by D. Papamichael Breakdown of academic impact, for papers by M. Homerin Breakdown of academic impact, for papers by J-Y Douillard Breakdown of academic impact, for papers by Axel Grothey Breakdown of academic impact, for papers by Daniel Hendler
Rankless by CCL
2026